Acura Pharmaceuticals Signs Secured Promissory Note Amendment With Abuse Deterrent Pharma
I'm PortAI, I can summarize articles.
Acura Pharmaceuticals has amended its secured promissory note with Abuse Deterrent Pharma, receiving additional advances totaling $100,000 on three dates in January 2026. The note's principal now stands at $9.59 million with a 5.25% interest rate. The funds will support the company's operations as it seeks further financing, with the agreement effective until June 30, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments